Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-09-23 07:32 am Unchanged | 2024-09-23 | 13D | Calliditas Therapeutics AB (publ) CALT | Asahi Kasei Corp | 53,156,176 98.380% | 0 (Unchanged) | Filing History |
| 2024-09-17 07:55 am Purchase | 2024-09-13 | 13D | Calliditas Therapeutics AB (publ) CALT | Asahi Kasei Corp | 53,156,176 98.380% | 2,743,279 (+5.44%) | Filing History |
| 2024-09-11 7:42 pm Sale | 2024-09-02 | 13G | Calliditas Therapeutics AB (publ) CALT | BIOTECHNOLOGY VALUE FUND L P | 0 0.000% | -6,260,311 (Position Closed) | Filing History |
| 2024-09-09 8:57 pm Unchanged | 2024-09-09 | 13D | Calliditas Therapeutics AB (publ) CALT | Asahi Kasei Corp | 50,412,897 93.300% | 0 (Unchanged) | Filing History |
| 2024-09-03 9:55 pm Purchase | 2024-09-02 | 13D | Calliditas Therapeutics AB (publ) CALT | Asahi Kasei Corp | 50,412,897 93.300% | 21,081,686 (+71.87%) | Filing History |
| 2024-06-04 4:56 pm Purchase | 2024-05-27 | 13D | Calliditas Therapeutics AB (publ) CALT | Asahi Kasei Corp | 29,331,211 54.600% | 29,331,211 (New Position) | Filing History |
| 2023-02-14 11:50 am Sale | 2022-12-31 | 13G | Calliditas Therapeutics AB (publ) CALT | BIOTECHNOLOGY VALUE FUND L P | 6,260,311 10.500% | -1,171,251 (-15.76%) | Filing History |
| 2023-02-01 4:55 pm Sale | 2022-12-31 | 13G | Calliditas Therapeutics AB (publ) CALT | FJARDE AP-FONDEN /FOURTH SWEDISH NATIONAL PENSION FUND | 2,663,000 4.500% | -12,000 (-0.45%) | Filing History |
| 2023-01-26 10:27 am Sale | 2022-12-31 | 13G | Calliditas Therapeutics AB (publ) CALT | Swedbank Robur Fonder AB | 0 0.000% | -2,638,107 (Position Closed) | Filing |
| 2022-03-02 4:07 pm Purchase | 2021-12-31 | 13G | Calliditas Therapeutics AB (publ) CALT | Linc AB | 5,486,108 10.500% | 5,486,108 (New Position) | Filing History |
| 2022-02-14 4:06 pm Purchase | 2021-12-31 | 13G | Calliditas Therapeutics AB (publ) CALT | FJARDE AP-FONDEN /FOURTH SWEDISH NATIONAL PENSION FUND | 2,675,000 5.100% | 2,675,000 (New Position) | Filing History |
| 2022-02-14 08:53 am Purchase | 2021-12-31 | 13G | Calliditas Therapeutics AB (publ) CALT | Swedbank Robur Fonder AB | 2,638,107 5.040% | 2,638,107 (New Position) | Filing |
| 2020-11-12 5:11 pm Purchase | 2020-11-09 | 13G | Calliditas Therapeutics AB (publ) CALT | BIOTECHNOLOGY VALUE FUND L P | 7,431,562 14.900% | 2,650,000 (+55.42%) | Filing History |
| 2020-06-08 10:27 am Purchase | 2020-06-05 | 13G | Calliditas Therapeutics AB (publ) CALT | BIOTECHNOLOGY VALUE FUND L P | 4,781,562 9.700% | 4,781,562 (New Position) | Filing History |